Department of Microbiology and Molecular Genetics, School of Medicine, University of California Irvine, Irvine, California, United States of America.
PLoS One. 2009 Dec 8;4(12):e8204. doi: 10.1371/journal.pone.0008204.
Spinal Muscular Atrophy (SMA) is an autosomal recessive disease that leads to specific loss of motor neurons. It is caused by deletions or mutations of the survival of motor neuron 1 gene (SMN1). The remaining copy of the gene, SMN2, generates only low levels of the SMN protein due to a mutation in SMN2 exon 7 that leads to exon skipping.
METHODOLOGY/PRINCIPAL FINDINGS: To correct SMN2 splicing, we use Adenovirus type 5-derived vectors to express SMN2-antisense U7 snRNA oligonucleotides targeting the SMN intron 7/exon 8 junction. Infection of SMA type I-derived patient fibroblasts with these vectors resulted in increased levels of exon 7 inclusion, upregulating the expression of SMN to similar levels as in non-SMA control cells.
CONCLUSIONS/SIGNIFICANCE: These results show that Adenovirus type 5-derived vectors delivering U7 antisense oligonucleotides can efficiently restore full-length SMN protein and suggest that the viral vector-mediated oligonucleotide application may be a suitable therapeutic approach to counteract SMA.
脊髓性肌萎缩症(SMA)是一种常染色体隐性疾病,导致运动神经元的特定丧失。它是由运动神经元生存 1 基因(SMN1)的缺失或突变引起的。由于 SMN2 外显子 7 中的突变导致外显子跳跃,基因的剩余拷贝 SMN2 仅产生低水平的 SMN 蛋白。
方法/主要发现:为了纠正 SMN2 剪接,我们使用腺病毒 5 型衍生载体表达针对 SMN 内含子 7/外显子 8 连接点的 SMN2-反义 U7 snRNA 寡核苷酸。用这些载体感染来自 SMA 型 I 的患者成纤维细胞,导致外显子 7 包含水平增加,上调 SMN 的表达,使其与非 SMA 对照细胞相似。
结论/意义:这些结果表明,携带 U7 反义寡核苷酸的腺病毒 5 型衍生载体可以有效地恢复全长 SMN 蛋白,并表明病毒载体介导的寡核苷酸应用可能是一种治疗 SMA 的合适方法。